The Effect of Pivotal Response Treatment on children with Autism Spectrum Disorder

Not Applicable

• Conditions: Autism.; Autistic disorder; F84.0

• Registration Number: IRCT20180617040124N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Aged 6;0 to12 years old at the start of the study
Diagnosis of autism spectrum disorder: Participants must have a diagnosis of an autism spectrum disorder as assessed by a child psychiatrist or clinical psychologist according to DSM-V criteria before their baseline assessment. This judgment will be supported by the results of gold-standard diagnostic instruments—the GARS(Gilliam Autism Rating Scale)—administered by two speech pathologist
high function autistic children: to earn score 30-36 in CARS
Mean Length of Utterance( MLU) of at least two words
No spontaneous questions in the speech
no receive verbal initiation training while entering the study
no receive other behavioral treatments during treatment in the intervention group
All participants must be right handed
parents must agree to participate in the intervention sessions
the loss of other Health impairment such as visual or hearing impairments
the loss of epilepsy or brain injury
the loss of other psychiatric Disorders ((e.g., schizophrenia, ADHD)
the loss of spike wave in EEG
Do not take medication or take similar medications

Exclusion Criteria

Parental dissatisfaction or disagreement to continue attending treatment sessions
Disconnecting the child in the study
Missing more than 3 sessions of treatment sessions

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Verbal initiation ability. Timepoint: Befor and after treatment. Method of measurement: Parents report and parent's interaction with her child.

Secondary Outcome Measures

Name	Time	Method
Power spectral density. Timepoint: Before and after treatment. Method of measurement: Quantitative Electroencephalography.